Kora Doorduyn-van der Stoep
Medicines Evaluation Board MEB), Utrecht, The Netherlands
Chairperson CMDh EU representative at the MEB; Kora Doorduyn works at the Medicines Evaluation Board (MEB) in The Netherlands. She held several positions within the MEB, both regulatory and management. Her current position (since 2009) is CMDh member (EU-representative)/Senior Policy adviser. Since May 2009 she is acting as Member and official representative in the CMDh (Co-ordination Group Mutual Recognition and Decentralised Procedures - Human) on behalf of the MEB. In December 2018 she was elected as Vice-Chairperson of CMDh. She is member of several working parties of CMDh with issues related to Pharmacovigilance legislation (like RMPs/PSUSA's) and variations as an area for special attention. She is acting as CMDh rapporteur for a (HaRP) project to harmonise RMPs for the same active substance in the EU. She is coordinator/Rapporteur EU Training Curriculum for Regulatory experts (for CMDh). She is the NL member of the Notice to Applicants Working Group in Brussels. She graduated MSc Pharmacy (in 1983) and as a pharmacist (in 1985).
Dr. Christian M. Moers
Sträter Lawyers, Bonn, Germany
Lawyer;
His prime interests are the interdisciplinary challenges of medicinal product law. His focal advisory areas are as follows:
- European and German medicinal product law
- Marketing authorisation law & regulatory affairs
- Pharmacovigilance
- Wholesale trade with medicinal products, distribution of medicinal products
- Manufacture of medicinal products
More information please click here.
Liane van Houte-Pluimgraaff
College ter Beoordeling van Geneesmiddelen Utrecht, THE NETHERLANDS
Senior Regulatory Project Leader
Émanuela Negri
Regulatory Affairs, Compliance and Pharmacovigilance Consultant, ITALY
Regulatory Affairs, Compliance and Pharmacovigilance Consultant, ITALY
Dr.ssa Ida Caramazza
Senior Expert Regulatory Affairs, ITALY
Ida Caramazza has a Degree in Pharmaceutical Technology and Chemistry and a Diploma as Specialist in Toxicology . She has been working in the Pharmaceutical field since the '80s. Her experience started with preclinical research activity in Pharmaceutical Companies and then continued in the regulatory affairs sector, working for Regulatory Consultancy Firms and for international Pharmaceutical Companies, being involved in Regulatory Affairs activities mainly on medicinal products, but also on other healthcare products, such as medical devices, food supplements and cosmetics. Currently she works as Senior Regulatory Affairs Consultant on regulatory strategy projects, regulatory activities, training in regulatory field. She is also involved in teaching activities at University masters in Regulatory Sciences.
Ingrid Prieschl
Zwiers Regulatory Consultancy B.V., A ProductLifeGroup Company, Oss, THE NETHERLANDS
Regulatory Consultant
More information please click here.
Karl-Heinz Loebel
PharmaLex GmbH, Mannheim; GERMANY
Director, Principal Consultant Regulatory Operations
Nach seinem Studium war Herr Loebel mehrere Jahre Mitarbeiter der Universität Heidelberg bevor er im Jahr 2000 zu einem Biotechnologie-Startup-Unternehmen wechselte. 2005 begann seine Laufbahn bei der PharmaLex GmbH, Mannheim, wo er zunächst die Position des Head of Regulatory Operations und seit 2014 die Position des Associate Director Regulatory Operations innehat. Sein Aufgabengebiet umfasst u.a. die Betreuung elektronischer Einreichungen, Projektplanung und die strategische Beratung von Pharma-Unternehmen in diesem Bereich.
More information please click here.
27-29/09/2023
27-29/09/2023
Day 1: 09:00 - 17:00Day 2: 09:00 - 1...
Day 1: 09:00 - 17:00
Day 2: 09:00 - 17:00
Day 3: 09:00 - 17:00
online
online
Event - 1,190 € plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
The fee includes a comprehensive e-documentation for download and a certificate
OPTIONS
Main course 1
+0,00 €
Main course 1 + 2
+700,00 €
Main course 1 + 2 + 3
+1.600,00 €
Event - 1,190 € plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
The fee includes a comprehensive e-documentation for download and a certificate
OPTIONS
Main course 1
+0,00 €
Main course 1 + 2
+700,00 €
Main course 1 + 2 + 3
+1.600,00 €
Dr. Rebekka Bitsch
+49 6221 500-565
r.bitsch@forum-institut.de
Do you need essential European regulatory affairs knowledge? This online training course gives you a compact overview on all important issues. The training course will be entirely held in English.
This online introductory training course will inform you about all the important obligations and challenges in regulatory affairs.
You will learn about the different procedures in Europe and about the data and documents required for successful marketing authorisations. Moreover, you will gain practical knowledge about the regulatory lifecycle management for a product and the structure and submission of an electronic dossier.
08:00 - 17:00 Workshop 1: Basic principles of drug regulatory affairs
09:00 - 09:15 Welcoming and introduction round
09:15
Kora Doorduyn-van der Stoep
10:30 Coffee break
10:45
Dr Christian M. Moers
12:00 Lunch break
13:00
Kora Doorduyn-van der Stoep
14:30
Liane van Houte-Pluimgraaff
15:45 Coffee break
16:00
Kora Doorduyn-van der Stoep
16:30 Q&As Day 1
17:00 End of Day 1
08:00 - 17:00 Workshop 2: Marketing Authorisation Documents
09:00 Welcoming and introduction round
09:15
Emanuela Negri
10:15
Nora Rieksta
11:15 Coffee break
11:30
Emanuela Negri
12:30 Lunch break
13:15
Emanuela Negri
13:15
Emanuela Negri
14:34 - 14:45
Dr Ida Caramazza
15:40 Coffee break
15:50
Ida Caramazza
16:50 Q&As Day 2
17:00 End of Day 2
08:00 - 17:00 Workshop 3: Regulatory Life Cycle Management
09:00
Ingrid Prieschl
10:45 Coffee break
11:00
Ingrid Prieschl
12:30 Lunch break
13:30
Karl-Heinz Loebel
15:00 Coffee break
15:15
Karl-Heinz Loebel
16:50 Q&As Day 3
17:00 End of Seminar
September 27, 2023
September 28, 2023
September 29, 2023
The European Pharmaceutical Law Review (EPLR) is a one-stop forum for analysis of pharmaceutical law and policy developments in the EU and offers in-depth lead articles, country and thematic reports, case notes and an overview of legislative and regulatory developments.
Overall score of all evaluations in 2022
Five stars on Trustpilot = Excellent
Our global and local experts will update you every two months with the latest regulatory and legislative developments. T...
5 consecutive webcasts - Pharmacovigilance in China, LATAM, EAEU, MENA, Latin America and on strategic questions
This e-Learning programme will familiarise you with the data requirements in CTD Module 3.
This e-Learning programme will focus on stability testing for chemical and biological products in the ICH region.
The latest on EU digital programmes (PLM, SPOR, ePI, etc.) and implementation in your sector.
We provide flexible education and training with high-quality e-Learning programmes for several topics.
DetailsHere you can find the technical requirements for our online events that must be met.
DetailsWe team up with other companies and experts to fulfill projects worldwide.
Details